Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2009/091/000872
CTRI/2009/091/000872CompletedPhase 4

Prospective Randomized 12-Week Controlled Study Of Visual Field Change In Subjects With Partial Seizures Receiving Pregabalin Or Placebo - Not applicable

Pfizer Limited0 sites29 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
29
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •a. Ages Eligible for Study: 18 Years to 65 Years
  • •b. Genders Eligible for Study: Both
  • •c. Accepts Healthy Volunteers: No
  • •1.Epilepsy partial seizure subjects.

Exclusion Criteria

  • •Pre-existing eye diseases.

Investigators

Similar Trials

Active, not recruiting
Not Applicable
Prospective Randomized 12-Week Controlled Study of Visual Field Change in Subjects with Partial Seizures Receiving Pregabalin or PlaceboEPILEPSY WITH PARTIAL SEIZUREMedDRA version: 16.0Level: LLTClassification code 10065336Term: Partial epilepsySystem Organ Class: 100000004852
EUCTR2009-014269-25-CZPfizer Inc284
Active, not recruiting
Phase 1
Prospective Randomized 12-Week Controlled Study of Visual Field Change in Subjects with Partial Seizures Receiving Pregabalin or Placebo
EUCTR2009-014269-25-BGPfizer Inc284
Active, not recruiting
Phase 1
Prospective Randomized 12-Week Controlled Study of Visual Field Change in Subjects with Partial Seizures Receiving Pregabalin or PlaceboEPILEPSY WITH PARTIAL SEIZUREMedDRA version: 14.1Level: LLTClassification code 10065336Term: Partial epilepsySystem Organ Class: 100000004852
EUCTR2009-014269-25-PLPfizer Inc, 235 East 42nd Street New York, NY 10017187
Active, not recruiting
Phase 1
Prospective Randomized 12-Week Controlled Study of Visual Field Change in Subjects with Partial Seizures Receiving Pregabalin or PlaceboEPILEPSY WITH PARTIAL SEIZUREMedDRA version: 17.0Level: LLTClassification code 10065336Term: Partial epilepsySystem Organ Class: 100000004852
EUCTR2009-014269-25-HUPfizer Inc284
Recruiting
Phase 2
Prospective Randomized Controlled Clinical Study for Lung Health Beverage in Preventing Radiotherapy-Related Lung Diseases in Locally Advanced Esophageal Canceresophageal cancer
ITMCTR2000003345Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine